Axikin Pharmaceuticals
San Diego
About Axikin Pharmaceuticals
Axikin Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused exclusively on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis. Axikin was spun out from Actimis Pharmaceuticals, in June 2008.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $18.5M
- Last round: Series Unknown (Sep 2015)
- Website: axikin.com
- Phone: (858)458-1890
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/axikin-pharmaceuticals-2855363 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.